NPI: 1083971071 · OAKLAND PARK, FL 33334 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/16/2012
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 04/16/2012 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,659 | $1.73M |
| 2019 | 12,437 | $2.10M |
| 2020 | 12,058 | $1.81M |
| 2021 | 5,429 | $279K |
| 2022 | 5,897 | $106K |
| 2023 | 150 | $14K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,541 | 652 | $2.15M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 15,630 | 999 | $1.96M |
| J1270 | Injection, doxercalciferol, 1 mcg | 8,118 | 525 | $971K |
| A4657 | Syringe, with or without needle, each | 1,847 | 829 | $295K |
| J1756 | Injection, iron sucrose, 1 mg | 1,869 | 359 | $225K |
| 85041 | 940 | 651 | $107K | |
| 85048 | 940 | 650 | $106K | |
| 83970 | 392 | 268 | $53K | |
| 83550 | 346 | 240 | $43K | |
| 83540 | 346 | 240 | $43K | |
| 82728 | 343 | 240 | $42K | |
| 85045 | 224 | 160 | $33K | |
| 82746 | 44 | 34 | $3K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 50 | 32 | $3K |